Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pheochromocytoma 4Paraganglioma 4Neuroendocrine Tumors 4Meningioma 2Gastro-enteropancreatic neuroendocrine tumor 2von Hippel-Lindau Disease 1Thyroid cancer, Hurthle cell 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Kidney Neoplasms 1Hypertension 1Head and Neck Neoplasms 1Carcinoma, Medullary 1Breast Neoplasms 1Adenocarcinoma, Follicular 1

Interventions

gallium Ga 68 dotatate 1cemiplimab 1Surgical Procedures, Operative 1Magnetic Resonance Spectroscopy 1Interviews as Topic 1Fluorodeoxyglucose F18 1FAPI-46 1Decision Support Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Carcinoma, Medullary × gallium Ga 68 dotatate × Clear all
NCT06520319 2024-07-25

Head-to-head Study of 68Ga-MGS5 Versus 68Ga-DOTATATE PET/CT in Patients With Medullary Thyroid Carcinoma

First Affiliated Hospital of Fujian Medical University

Phase 1 Recruiting
20 enrolled

Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡